US Stock MarketDetailed Quotes

QTTB Q32 Bio

Watchlist
  • 3.590
  • +0.250+7.49%
Close Dec 20 16:00 ET
  • 3.610
  • +0.020+0.56%
Post 20:01 ET
43.73MMarket Cap-0.27P/E (TTM)

About Q32 Bio Company

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.

Company Profile

SymbolQTTB
Company NameQ32 Bio
Listing DateMar 28, 2018
Founded2017
CEOMs. Jodie P. Morrison
MarketNASDAQ
Employees34
Fiscal Year Ends12-31
Address830 Winter Street,2nd floor
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Websitehttp://www.q32bio.com

Company Executives

  • Name
  • Position
  • Salary
  • Jodie P. Morrison
  • Chief Executive Officer and Director
  • --
  • Lee Kalowski, M.B.A.
  • Chief Financial Officer and President
  • --
  • Dr. Shelia M. Violette, PhD
  • Chief Scientific Officer and President, Research
  • --
  • Dr. Jason A. Campagna, M.D.,PhD
  • Chief Medical Officer
  • --
  • Mark T. Iwicki
  • Chairman of the Board
  • --
  • Dr. Arthur O. Tzianabos, PhD
  • Director
  • --
  • Dr. David S. Grayzel, M.D.
  • Independent Director
  • --
  • Dr. Bill Lundberg
  • Independent Director
  • --
  • Mary T. Thistle
  • Independent Director
  • --
  • Kathleen D. Laporte
  • Independent Director
  • --
  • Diyong Xu
  • Independent Director
  • --
  • Dr. Isaac Manke
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data